Since the last World Symposium on Pulmonary Hypertension in 2008, we have witnessed
numerous and exciting developments in chronic thromboembolic pulmonary hypertension …

Background We aimed to determine the risk of recurrence for symptomatic venous
thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE …

The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with
malignancy remains undefined. In particular, based on current evidence, it is uncertain …

Background Chronic thromboembolic pulmonary hypertension (CTPH) is associated with
considerable morbidity and mortality. Its incidence after pulmonary embolism and …

Background Bleeding is the most serious complication of the use of oral anticoagulation in
the prevention and treatment of thromoboembolic complications. We studied the frequency …

One of the conclusions of the subcommittee meeting on Lupus Anticoagulant/Phospholipid
dependent antibodies, held in Geneva on 2007, was the need to update the guidelines on …

Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …

Abstract Background and Objectives While it has long been recognized that patients with
acute unprovoked deep vein thrombosis (DVT) or pulmonary embolism (PE) have a higher …

Background The optimal duration of oral anticoagulation in patients with idiopathic venous
thromboembolism is uncertain. Testing of d-dimer levels may play a role in the assessment …

The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …